These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35912669)

  • 1. Improvement of type 2 diabetes in a bipolar patient after initiation of atypical antipsychotic therapy.
    Claro AE; Palanza C; Mazza M; Rizzi A; Tartaglione L; Marano G; Muti Schuenemann GE; Rigoni M; Muti P; Pontecorvi A; Janiri L; Sani G; Pitocco D
    Minerva Endocrinol (Torino); 2024 Jun; 49(2):226-228. PubMed ID: 35912669
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes mellitus induced by an atypical antipsychotic medication.
    Sneed KB; Gonzalez EC
    J Am Board Fam Pract; 2003; 16(3):251-4. PubMed ID: 12755254
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature.
    Ghaemi SN; Goodwin FK
    J Clin Psychopharmacol; 1999 Aug; 19(4):354-61. PubMed ID: 10440464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine-associated type 2 diabetes mellitus.
    Opp D; Hildebrandt C
    Schizophr Res; 2002 Jul; 56(1-2):195-6. PubMed ID: 12084434
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder.
    McIntyre RS; Konarski JZ
    J Clin Psychiatry; 2005; 66 Suppl 3():28-36. PubMed ID: 15762832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of atypical antipsychotics in rapid cycling bipolar disorder: a review of the literature.
    Zupancic ML
    Ann Clin Psychiatry; 2011 May; 23(2):141-9. PubMed ID: 21547275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of atypical antipsychotics in bipolar disorders.
    Hirschfeld RM
    J Clin Psychiatry; 2003; 64 Suppl 8():15-21. PubMed ID: 12892537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare costs of atypical antipsychotic use for patients with bipolar disorder in a Medicaid programme.
    Qiu Y; Fu AZ; Liu GG; Christensen DB
    Appl Health Econ Health Policy; 2010; 8(3):167-77. PubMed ID: 20408601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder.
    Burghardt KJ; Seyoum B; Dass SE; Sanders E; Mallisho A; Yi Z
    Pharmacotherapy; 2018 Apr; 38(4):428-435. PubMed ID: 29484683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder.
    Erickson SC; Le L; Zakharyan A; Stockl KM; Harada AS; Borson S; Ramsey SD; Curtis B
    J Am Geriatr Soc; 2012 Mar; 60(3):474-9. PubMed ID: 22288652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine-associated hyperglycemia and hypertriglyceridemia.
    Domon SE; Cargile CS
    J Am Acad Child Adolesc Psychiatry; 2002 May; 41(5):495-6. PubMed ID: 12014779
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine and improvement of tardive dyskinesia.
    Kucerová H
    Eur Psychiatry; 2002 Nov; 17(7):421-4. PubMed ID: 12547311
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipsychotic agents and bipolar disorder.
    Tohen M; Zarate CA
    J Clin Psychiatry; 1998; 59 Suppl 1():38-48; discussion 49. PubMed ID: 9448668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of diabetes in patients with bipolar disorder in Taiwan: a population-based national health insurance study.
    Chien IC; Chang KC; Lin CH; Chou YJ; Chou P
    Gen Hosp Psychiatry; 2010; 32(6):577-82. PubMed ID: 21112448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of bipolar disorder in children and adolescents: recent progress.
    Pfeifer JC; Kowatch RA; DelBello MP
    CNS Drugs; 2010 Jul; 24(7):575-93. PubMed ID: 20441242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone-associated mania: a case series and review of the mechanism.
    Baldassano CF; Ballas C; Datto SM; Kim D; Littman L; O'Reardon J; Rynn MA
    Bipolar Disord; 2003 Feb; 5(1):72-5. PubMed ID: 12656943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].
    Verdoux H; Gaudron Y; Auleley GR; Deligne J; Blum-Boisgard C; Thiébaut A; Tournier M
    Encephale; 2013 May; 39 Suppl 1():S22-8. PubMed ID: 23246328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.